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Abstract
Reprogramming of somatic cells to pluripotency, thereby creating induced pluripotent stem (iPS)
cells, promises to transform regenerative medicine. Most instances of direct reprogramming have
been achieved by forced expression of defined factors using multiple viral vectors1-7. However,
such iPS cells contain a large number of viral vector integrations1,8, any one of which could cause
unpredictable genetic dysfunction. While c-Myc is dispensable for reprogramming9,10, complete
elimination of the other exogenous factors is also desired since ectopic expression of either Oct4
or Klf4 can induce dysplasia11,12. Two transient transfection reprogramming methods have been
published to address this issue13,14. However, the efficiency of either approach is extremely low,
and neither has thus far been applied successfully to human cells. Here we show that non-viral
transfection of a single multiprotein expression vector, which comprises the coding sequences of
c-Myc, Klf4, Oct4 and Sox2 linked with 2A peptides, can reprogram both mouse and human
fibroblasts. Moreover, the transgene can be removed once reprogramming has been achieved. iPS
cells produced with this non-viral vector show robust expression of pluripotency markers,
indicating a reprogrammed state confirmed functionally by in vitro differentiation assays and
formation of adult chimeric mice. When the single vector reprogramming system was combined
with a piggyBac transposon15,16 we succeeded in establishing reprogrammed human cell lines
from embryonic fibroblasts with robust expression of pluripotency markers. This system
minimizes genome modification in iPS cells and enables complete elimination of exogenous
reprogramming factors, efficiently providing iPS cells that are applicable to regenerative
medicine, drug screening and the establishment of disease models.
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Efficient multiprotein expression has been reported in a variety of cell types, including
human ES cells, using the 2A peptide sequence of foot-and-mouth disease virus (F2A), or
2A-like sequence from other viruses17,18. Recently, this multiprotein expression strategy
has also been applied for reprogramming with transient transfection14 and doxycycline
(dox)-inducible lentiviral vector19,20. Here we have taken advantage of the strategy to
generate virus-free factor-removable iPS cells flanking a 2A-peptide-linked reprogramming
cassette, c-Myc-Klf4-Oct4-Sox2 (MKOS)-ires-mOrange, by loxP sites (Supplementary
Figure 1). Initially we investigated whether the 2A peptide-mediated multiprotein expression
could achieve robust expression of c-Myc, Klf4, Oct4 and Sox2, when transcribed from the
ubiquitously expressed synthetic CAG enhancer/promoter21. When the vector was
transfected into HEK293 cells, expression of Klf4, Oct4 and Sox2 could be detected by
immunoblotting (Supplementary Figure 2a). While high expression of endogenous c-Myc in
HEK293 cells precluded clear identification of exogenous c-Myc, a phosphorylated form at
Thr 58 that was subjected to subsequent ubiquitination22 was enriched in the transfectants,
suggesting excess c-Myc was degraded (Supplementary Figure 2a, b). Appropriate nuclear
localization of exogenous Oct4 and Sox2 was also observed in the transfected HEK 293
cells (Supplementary Figure 2c).
When the vector, pCAG2LMKOSimO, was introduced into MEFs, some mOrange positive
cells converted to an ES cell-like morphology at day 5-6, and by day 9 colonies containing
alkaline phosphatase positive cells appeared (data not shown). Moreover morphologically
ES cell-like colonies picked between days 20-30 succeeded to grow maintaining an ES cell-
like morphology on gelatin (Supplementary Figure 3a). We then went on to estimate the
reprogramming efficiency using Nanog reactivation as a marker of reprogramming3,4.
MEFs from TNG mice, which have a GFP reporter inserted at the Nanog start codon23, and
MEFs from wild-type 129 mice were transfected with the pCAG2LMKOSimO plasmid and
cultured on either γMEFs or gelatin. The number of transiently transfected mOrange
positive cells was measured by flow cytometry at day 2. The number of reprogrammed
colonies judged by GFP positivity (TNG MEFs) or anti-Nanog immunofluorescence (129
MEFs) (Supplementary Figure 3b) was scored at day 28 (Table 1). By comparing stable
transfection efficiency with Nucleofection (3.6 % of transiently transfected cells, see
Supplementary Figure 3c for details) and the number of reprogrammed colonies, we
calculate overall reprogramming effiiency as average 2.5% (Supplementary Table 1). While
the estimation method is different from that used in viral reprogramming systems
(efficiency; ∼0.1% 2,3,7), this relatively high efficiency may depend on several factors in
this non-viral method, including expression of the four reprogramming factors from a single
transcript and use of the CAG enhancer/promoter, which may be less prone to silencing.
Stable cell lines were established by picking colonies derived from transfection of 129
MEFs (8/12 morphologically ES cell-like colonies picked) and TNG MEFs (5/9 GFP
positive colonies picked) with pCAG2LMKOSimO. We examined the expression of the
reprogramming factors in 8 cell lines, imO1-imO8. All cell lines showed robust reactivation
of endogenous Oct4 and Sox2, comprising the majority of total Oct4 and Sox2 transcripts
(Figure 1a). Endogenous c-Myc expression, which was higher in MEFs than ES cells,
became similar to ES cells in all cell lines, while there was no large change in endogenous
Klf4 expression levels (Figure 1a). Total c-Myc and Klf4 expression were high relative to
ES cells, but total Oct4 and Sox2 expression were not, although the exogenous transcript
encodes all four genes. This observation could be explained by the fact that the expression
level of c-Myc and Klf4 is lower than that of Oct and Sox2 in ES cells (c-
Myc<Klf4<Oct4≅Sox2, quantified by real-time PCR, data not shown). The total amount of
the four reprogramming factor proteins was also comparable to ES cells in all cell lines
examined (Supplementary Figure 4a). In conjunction with Oct4 and Sox2, 13 additional
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pluripotent markers, which are highly enriched in both ES cells and iPS cells1,4,24, were
reactivated in all cell lines screened (Figure 1b). Bisulphite genomic sequencing analyses
revealed that the promoter region of Oct4 and Nanog is highly unmethylated in the iPS cells
(Supplementary Figure 4c). These results indicate that efficient reprogramming had occurred
due to the non-viral single vector.
The number of vector integration sites was analyzed by Southern blotting in cell lines imO1-
imO8, as well as 5 TNG iPS cell lines, TNGimO1-imO5 (strategy shown in Figure 2a). Of
the 13 cell lines, imO7 and TNGimO5 were found to have a single vector integration in one
site, indicating that a stable single-copy insertion of the non-viral expression vector can
achieve direct reprogramming, effectively minimizing genome modification in iPS cells
(Figure 2b). We did not find reprogrammed cell lines without vector integration. The
integration sites of imO1, imO3 and imO7, as well as the tandem repeats in imO1 and imO3,
were identified by inverse PCR and confirmed by genomic PCR (Supplementary Figure S5
and Figure 2c). All integration sites of the individual cell lines are different, supporting the
notion that reprogramming does not depend upon vector integration at specific loci8.
Expression of the genes at the integration sites was detectable in MEFs, ES cells, and all
examined iPS cell lines, without significant influence imposed by vector integration
(Supplementary Figure 5d). Adult cells (footpad fibroblasts) were also succesfully
reprogrammed via definite single-copy vector integration (Supplementary Figure 6).
To remove the exogenous reprogramming factors, we performed transient Cre transfection
and tracked the loss of fluorescent reporter expression. Surprisingly, many of the mOrange
negative colonies started to differentiate after Cre transfection (Supplementary Figure 7a).
This excision-mediated differentiation was prevented by culturing the cells in the presence
of the Fgf receptor inhibitor, PD173074, which inhibits mouse ES cell differentiation25
(Figure 3a). The percentage of differentiated colonies after Cre-mediated excision differed
among clones, possibly reflecting variable stability of the reprogrammed state (Figure 3b).
All tested reprogramming cassette-excised clones, which were generated from imO2, imO3,
imO7 and TNGimO5 and expanded in the presence of PD173074, could subsequently
maintain an undifferentiated morphology for at least 5 passages after removal of PD173074
(data not shown). The presence of PD173074 may allow cells to adapt upon rapid loss of
exogenous reprogramming factors in single cells at colony density. Whereas Cre-excised
cell lines from imO7 and TNGimO5 could be maintained over 20 passages while
maintaining an undifferentiated morphology, cell lines derived from imO2 and imO3 were
prone to generate more differentiated cells at later passages in the absence of PD173074,
suggesting a different reprogramming level for each clone (data not shown). The
endogenous gene expression of c-Myc, Klf4, Sox2, and Oct4 was maintained in the Cre-
excised cell lines, imO2Ec3, imO3c8 and imO7c8, which are derived from imO2 with
additional constitutive EGFP expression imO2E1, imO3 and imO7, respectively
(Supplementary Figure 8a). Expression of other pluripotency genes was sustained
(Supplementary Figure 8b), indicating that our single-vector system has enabled complete
elimination of exogenous genes without disturbing maintenance of the iPS cell state.
We next examined the differentiation ability of the cell lines before and after reprogramming
cassette excision. Cre-excised cell lines imO3c8 and imO7c8 downregulated the
pluripotency markers Oct4, Nanog and Rex1, and up-regulated markers of all three germ
layers in embryoid bodies, thus behaving in the same way as ES cells26 (Supplementary
Figure 9a). Furthermore, β-tubulin positive neurons were generated efficiently in a
monolayer neural differentiation protocol27 (Supplementary Figure 9b). Differentiation of
the factor-retained parental cell lines imO3 and imO7 was less efficient (Supplementary
Figure 9a, b). Both imO7 and imO7c8 produced teratocarcinomas when transplanted to the
kidney capsule, although imO7 tumours contained more undifferentiated cells than those
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from imO7c8 tumours (Figure 3c). Finally we injected the reprogramming vector-free iPS
cells into C57BL/6 blastocysts (results summarized in Supplementary Table 2). To identify
chimeric embryos two cell lines with constitutive EGFP expression, imO3Ec5 and
imO7Ec3, were used, and high contribution chimeric embryos were generated at high
frequency from both cell lines (Figure 3d and Supplementary Table 2). Contribution to all
three germ layers - ectoderm, mesoderm and endoderm - was observed, in addition to Oct4
positive germ cells in the 12.5dpc genital ridge (Figure 3e). Three Cre-excised iPS cell lines,
imO1c5, imO7c8 and TNGimO3cC5, gave rise to live chimeras, indicating iPS cells derived
with the non-viral multiprotein expression vector are genuinely pluripotent (Figure 3f).
To address the reprogramming ability of the non-viral single-vector system in human cells,
we enhanced stable transfection efficiencies using a piggyBac (PB) transposon gene delivery
system15. Co-transfection of two PB transposons carrying a doxycycline (dox) inducible
MKOS-ires-geo cassette and a constitutively active CAG-rtTA transactivator construct16
was applied to human embryonic fibroblasts (Supplementary Figure 10a). In this design,
upon genomic integration, the two transposons allow dox-inducible activation of MKOS
expression in wild-type cells. We observed iPS-like colony formation 14 days post
transfection (dpt) when the cells were maintained in hES cell culture conditions
supplemented with dox. In total, fifteen colonies were picked from 14-25dpt from four wells
of 6-well plates, initially containing either 3.2×104 or 6.4×104 fibroblasts/well. When dox
was withdrawn on 32dpt, three clones successfully propagated as stable cell lines, while the
exogenous factor expression was uninduced as indicated by negative staining for lacZ
activity (Supplementary Figure 10b). All clonal lines displayed human ES cell morphology
(Supplementary Figure 10b) and were positive for alkaline phosphatase (not shown). Robust
expression of endogenous pluripotency markers, SSEA4, NANOG, TRA-160 and TRA-181
was confirmed in all the three cell lines (Supplementary Figure 10c). These results
demonstrate that the non-viral single-vector system can reprogram human fibroblasts and
strongly suggests that it can also be applied to the production of exogenous factor-free, non-
viral human iPS cells.
We demonstrate that single non-viral vector with 2A peptide-linked reprogramming factors
can achieve reprogramming efficiently and the exogenous reprogramming factors can be
completely removable from the iPS cells using subsequent Cre-transfection. Absolute
avoidance of unpredictable exogenous reprogramming factor reactivation is important not
only for clinical applications but also for drug screening, since some small molecules affect
epigenetic genome modification28 which could cause unexpected reactivation and
unreliable screening results. Cre recombinase boasts the most efficient in vivo and in vitro
recombination system currently known, and a part of the vector backbone remained in the
integration site following Cre-mediated factor deletion would be a tolerable remnant for in
vitro iPS applications. We also demonstrated the single-vector reprogramming system
combined with PB transposon delivery system for human cell reprogramming. PB
transposons are completely removable from their integration site without any residual
change in the original DNA sequence15,16. This PB-based single-vector reprogramming
system will enable the generation of non-genetically modified human iPS cells as shown in
the mouse16, which is ideal for regenerative medicine.
Methods Summary
A vector, pCAG2LMKOSimO, which have c-Myc, Klf4, Oct4 and Sox2 coding regions
linked with 2A peptide sequences driven by CAG enhancer/promoter18,21, were
constructed as described in the Methods. The vectors were introduced into MEFs using
Nucleofector II (Amaxa) and cells were cultured in ES cell culture condition for up to 4
weeks. Colonies showing ES cell-like morphology were picked and cultured either on
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irradiated MEFs (γMEFs) or gelatin after trypsinization. Gene expression, integration
number/sites of the vector in the established cell lines were analyzed by quantitative PCR,
immunoblotting, Southern blotting and inverse PCR, respectively. The reprogramming
cassette was excised by Cre transient transfection in the presence or absence of an Fgf
receptor inhibitor PD173074 (100 ng/ml), and pluripotency of the cell lines were examined
in vitro (embryoid body formation, neural differentiation) and in vivo (teratoma formation,
blastocyst injection).
Full Methods accompany this paper.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Efficient reactivation of pluripotent markers in iPS cells generated by a non-viral
multiprotein expression vector
a. Quantitative PCR for total and endogenous c-Myc, Klf4, Oct4 and Sox2 expression. Data
is shown as relative expression to an ES cell line, E14Tg2a (E14). Error bars indicate the
s.d. generated from triplicates. b. Quantitative PCR for pluripotent markers. Two
independent ES cell lines, E14Tg2a (E14) and CGR8, were analyzed together with iPS cell
lines. Data is shown as relative expression to E14Tg2a, and represents one of two
independent experiments.
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Figure 2. Non-viral iPS cells with a single vctor integration site
a. Schematic diagram of restriction enzyme sites, AflII and KpnI in pCAG2LMKOSimO
and two probes, CAG probe and Orange probe, used for Southern blotting (bars). Black
arrows (invAluR2, inv3TaqF1) indicate position of primers used to detect tandem repeat
integration in c. b. Southern blotting analysis for AflII (top two panels) and KpnI (bottom
two panels) digested genome of imO1-8 and TNGimO1-5, using CAG probe (left panels)
and Orange probe (right panels). c. Validation of the integration site and tandem repeat
integration. A single integration site of imO7 (white circle in b), and a single integration site
with tandem integration (same orientation) of imO1 and imO3 (black circles in b) was
identified by inverse PCR (data not shown) and validated by genomic PCR. Asterisk; band
from wild-type allele. Arrowhead; integration site-specific band. Detail of the integration
site is shown in Supplementary Figure 5. Note different band size of tandem repeats is
caused by vector degradation accompanied by random integration.
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Figure 3. Reprogramming cassette excision and pluripotency of the non-viral iPS cells
a. Many of the undifferentiated colonies at 5 days post Cre-transfection differentiated by day
9 in the absence of an Fgf receptor inhibitor, PD173074 (bottom). b. Percentage of
reprogramming cassette-free undifferentiated colonies in the absence (−PD) and presence
(+PD) of PD173074. Numbers of monitored reprogramming cassette-excised colonies are
indicated in parentheses. Experiments were performed in three cell lines, imO2, imO7 and
TNGimO5. c. Undifferentiated cells in imO7 teratoma (left) and various tissues in imO7c8
teratoma (the other three panels). d. imO3Ec5 derived chimeric embryos (green) at 10.5 dpc
(left panels). e. Transversal sections at 9.5 dpc (upper six panels) and genital ridge at 12.5
dpc (bottom panels). imO3Ec5 contributed to ectoderm (neural tissue; n with magnification),
mesoderm (heart; h), endoderm (gut; g with magnification) and germ cells (red staining with
anti-Oct4 antibody). f. An adult imO7c8 derived chimeric mouse.
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